Siga Technologies (SIGA) Inventory Average (2012 - 2025)
Siga Technologies' (SIGA) quarterly Inventory Average came in at $48.5 million in Q4 2025, down 13.02% on a YoY basis from $55.8 million in Q4 2024, and up 16.07% quarter-over-quarter from $41.8 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Inventory Average (2012 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Inventory Average for 14 consecutive years, with $48.5 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Inventory Average fell 13.02% year-over-year to $48.5 million; the trailing twelve-month figure through Dec 2025 stood at $48.5 million (down 13.02% YoY), and the FY2025 full-year result was $49.3 million, down 13.33% from the prior year.
- Inventory Average rose to $48.5 million in Q4 2025 per SIGA's latest filing, from $41.8 million in the prior quarter.
- Across five years, Inventory Average topped out at $64.6 million in Q4 2023 and bottomed at $16.4 million in Q2 2022.
- Historically, Inventory Average has averaged $41.1 million across 5 years, with a median of $44.2 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Inventory Average surged 184.56% in 2023, then fell 28.95% in 2025.
- Over 5 years, Inventory Average stood at $24.6 million in 2021, then soared by 43.41% to $35.3 million in 2022, then surged by 83.13% to $64.6 million in 2023, then retreated by 13.61% to $55.8 million in 2024, then retreated by 13.02% to $48.5 million in 2025.
- According to Business Quant data, Inventory Average over the past three periods registered $48.5 million, $41.8 million, and $47.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 6.25 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 114.08 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 186.05 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | 48.53 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 48.53 Mn |
| Sep 30, 2025 | 41.81 Mn |
| Jun 30, 2025 | 47.34 Mn |
| Mar 31, 2025 | 54.31 Mn |
| Dec 31, 2024 | 55.79 Mn |
| Sep 30, 2024 | 58.84 Mn |
| Jun 30, 2024 | 59.69 Mn |
| Mar 31, 2024 | 63.97 Mn |
| Dec 31, 2023 | 64.58 Mn |
| Sep 30, 2023 | 57.72 Mn |
| Jun 30, 2023 | 46.54 Mn |
| Mar 31, 2023 | 40.93 Mn |
| Dec 31, 2022 | 35.27 Mn |
| Sep 30, 2022 | 23.85 Mn |
| Jun 30, 2022 | 16.35 Mn |
| Mar 31, 2022 | 17.89 Mn |
| Dec 31, 2021 | 24.59 Mn |
| Sep 30, 2021 | 24.64 Mn |
| Jun 30, 2021 | 20.01 Mn |
| Mar 31, 2021 | 20.34 Mn |